Publication | Closed Access

β-carboline alkaloids attenuate bleomycin induced pulmonary fibrosis in mice through inhibiting NF-kb/p65 phosphorylation and epithelial-mesenchymal transition

InflammationMolecular PharmacologyFibrosisInflammatory Lung DiseaseLung InflammationMedicineNf-kb/p65 PhosphorylationImmunologyPulmonary PharmacologyCellular PharmacologyPulmonary Fibrosisβ-Carboline AlkaloidsPharmacotherapyPulmonary MedicinePharmacologyCell Biology